Abstract:Controllable and visible delivery of therapeutic agents is critical for tumor precise therapy. Tumor targeting and deep penetration of therapeutic agents are still challenging issues for controllable delivery. Visible drug delivery with imaging navigation can optimize the treatment window for personalized medicine. Herein, a biomimetic platelet intelligent vehicle with navigation (IRDNP-PLT) was developed to achieve controllable and visible delivery with a navigation system, a driving system, and a loading system. The platelets acted as engines and drug repositories to exert the target driving and delivery functions. The fluorescent photothermal agent IR-820 was introduced in the platform to offer an imaging navigation for the intelligent platelet vehicle in addition to photothermal therapy. The nanodrug-loaded platelets enabled efficient drug loading and controlled release of the therapeutic payload by encapsulating photothermal-/pH-sensitive chemotherapeutic nanoparticles ( NPs). In in vivo experiments on 4T1 tumor-bearing mice models, IRDNP-PLT performed well in tumor targeting and showed excellent therapeutic efficacy and tumor recurrence prevention ability. The intelligent platelet vehicle achieved the functions of tumor targeting and deep penetration, fluorescence imaging guidance, photocontrolled drug release, and chemo-photothermal combination therapy, suggesting the advancement for tumor precise delivery and efficient therapy.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.2c00453.Materials, cell culture and animal methods, details of the experimental section of the preparation and characterization of NPs, in vitro release process of Dox from NPs, photothermal imaging, isolation of platelets from whole blood, ex vivo distribution of multifunctional intelligent platelet vehicles, Dox transfer behavior between platelet vehicles and tumors, and statistical analysis, data of UV–vis spectra, size, fluorescence emission spectra, thermal images of NPs, CLSM images and multispectral fluorescence imaging of platelet vehicles, flow cytometry images of 4T1 cells co-incubated with platelet vehicles, ex vivo distribution of Dox in tumor-bearing mice, and H&E staining of the major organs from 4T1 tumor-bearing mice (PDF)This article has not yet been cited by other publications.

Recent advances in platelet engineering for anti-cancer therapies

Engineered Platelets for Cancer Therapy

Engineered Platelets: Advocates for Tumor Immunotherapy

The dynamic role of platelets in cancer progression and their therapeutic implications

Emerging roles of platelets in cancer biology and their potential as therapeutic targets

Advancement and Applications of Platelet-inspired Nanoparticles: A Paradigm for Cancer Targeting

Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells

Engineering Unactivated Platelets for Targeted Drug Delivery

Platelet-derived biomaterials for targeted drug delivery and tissue repair

In Situ Activation of Platelets with Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy

Engineering Platelet-Mimicking Drug Delivery Vehicles

From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery

Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies

Platelets and platelet extracellular vesicles in drug delivery therapy: A review of the current status and future prospects

Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment

Platelets and Their Biomimetics for Regenerative Medicine and Cancer Therapies

A Platelet Intelligent Vehicle with Navigation for Cancer Photothermal-Chemotherapy

Double-sided Effect of Tumor Microenvironment on Platelets Targeting Nanoparticles.

Engineering PD-1-Presenting Platelets for Cancer Immunotherapy.

T Cell-Mimicking Platelet-Drug Conjugates

Human Platelets Repurposed As Vehicles for in Vivo Imaging of Myeloma Xenotransplants